HemaSphere
(Jun 2022)
P1290: A TISSUE-BASED EX VIVO CULTURE SYSTEM TO ANTICIPATE TEHRAPY RESPONSE IN LYMPHOMA.
- A. Santamaria-Martínez,
- J. Epiney,
- D. Srivastava,
- D. Tavernari,
- D. Milowich,
- I. Letovanec,
- G. Ciriello,
- A. Cairoli,
- E. Oricchio
Affiliations
- A. Santamaria-Martínez
- 1 Swiss Institute for Experimental Cancer Research, EPFL
- J. Epiney
- 1 Swiss Institute for Experimental Cancer Research, EPFL
- D. Srivastava
- 1 Swiss Institute for Experimental Cancer Research, EPFL
- D. Tavernari
- 1 Swiss Institute for Experimental Cancer Research, EPFL
- D. Milowich
- 5 ICH, Hôpital du Valais, Sion, Switzerland
- I. Letovanec
- 5 ICH, Hôpital du Valais, Sion, Switzerland
- G. Ciriello
- 2 Swiss Cancer Center Léman
- A. Cairoli
- 3 Hemato-oncology department, CHUV
- E. Oricchio
- 1 Swiss Institute for Experimental Cancer Research, EPFL
- DOI
-
https://doi.org/10.1097/01.HS9.0000848024.58707.55
- Journal volume & issue
-
Vol. 6
pp.
1175
– 1176
WeChat QR code